Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences

Patients with cancer are at particular risk for infection but also have diminished vaccine responses, usually quantified by the level of specific antibodies. Nonetheless, vaccines are specifically recommended in this vulnerable patient group. Here, we discuss the cellular part of the vaccine respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Rüthrich, Maria Madeleine, Giesen, Nicola, Mellinghoff, Sibylle C., Rieger, Christina T., von Lilienfeld-Toal, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875094/
https://www.ncbi.nlm.nih.gov/pubmed/35214642
http://dx.doi.org/10.3390/vaccines10020182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875094/
https://www.ncbi.nlm.nih.gov/pubmed/35214642
http://dx.doi.org/10.3390/vaccines10020182

Ejemplares similares